Instrument Inactif

Communiqués Vitro Diagnostics, Inc.

Actions

VITRO DIAGNOSTICS INC : Regulation FD Disclosure (form 8-K)	05/10/20	AQ
VITRO DIAGNOSTICS INC : Other Events (form 8-K)	05/10/20	AQ
Vitro Diagnostics : Biopharma 2nd Quarter ended April 30th 2020 Financial Results of Operations	14/07/20	AQ
VITRO DIAGNOSTICS INC : Regulation FD Disclosure (form 8-K)	09/07/20	AQ
VITRO DIAGNOSTICS INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure (form 8-K)	04/06/20	AQ
Vitro Diagnostics : Biopharma First Quarter 2020 Financial Results of Operations	27/03/20	AQ
VITRO DIAGNOSTICS : Regulation FD Disclosure (form 8-K/A)	04/02/20	AQ
VITRO DIAGNOSTICS INC : Regulation FD Disclosure (form 8-K)	27/01/20	AQ
Vitro Diagnostics : Leading Denver-Based Orthopedic Surgeon to Join Vitro Biopharma's Scientific Advisory Board	23/01/20	AQ
VITRO DIAGNOSTICS : New Results Reveal Extensive Competitive Advantages of VitroGrow? Stem Cell Culture Media	14/12/10	BU
VITRO DIAGNOSTICS : Vitro Expands HemoGenix Alliance to Include Cell-based Testing for Liver Toxicity	19/10/10	BU
VITRO DIAGNOSTICS : Vitro Enters Contract to Develop Stem Cell-Derived Food	27/07/10	BU
VITRO DIAGNOSTICS : Vitro and HemoGenix® Launch New Products at an International Stem Cell Meeting	15/06/10	BU
VITRO DIAGNOSTICS : Vitro CEO Interviews with Wall Street Reporter Regarding New Stem Cell Tools for Cellular Medicine	20/05/10	BU

Aucun résultat pour cette recherche